Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
3
self-reported 2–10 band
Founded
Not recorded
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
3
Post IPO equity · Nov 2024 · US$ 2.4M
Company type
Public Company
self-reported
Legal entity
1 brand → 1 confirmed entity
ISLAND PHARMACEUTICALS LIMITED
ABN48641183842
Legal entities
Show as table · Island Pharmaceuticals: 1 registry entity
| ISLAND PHARMACEUTICALS LIMITED | ABN 48641183842 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Island Pharmaceuticals (ASX: ILA) is an Australian drug development company based in New South Wales, focused on addressing areas of unmet need in viral diseases with significant public health and biosecurity importance.
The Company is advancing ISLA-101, a repurposed antiviral drug candidate with a well-established safety profile. ISLA-101 is being developed for the prevention and treatment of dengue fever and other mosquito-borne viral diseases, targeting large global markets where effective therapeutic options remain limited.
Island’s strategy is centred on leveraging existing clinical data to accelerate development, reduce risk, and deliver meaningful outcomes in areas of high unmet medical need.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU697 Burke Road Camberwell,; Suite 201,; Melbourne, New South Wales 3124Primary
Grid intelligence Members
Funding
Last round · 3 November 2024US$ 2.4MPost IPO equity
Rounds3
Round typePost IPO equity · secondary transaction
Amount (USD)2,400,000
Stage rank6
Investors named0
Since last round1 yr 2 mo
Funding
Show as table · 3 funding rounds
| Rounds | 3 |
|---|---|
| Axis | 2024 to 2027 |
| Post IPO equity · 3 Nov 2024 | US$ 2.4M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
Which legal entity operates under Island Pharmaceuticals?
One Victoria entity on the ABR: ISLAND PHARMACEUTICALS LIMITED (ABN 48 641 183 842), high confidence.
How many people work at Island Pharmaceuticals?
3 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Island Pharmaceuticals have offices?
One address on record, Australia only. Primary: 697 Burke Road Camberwell, Suite 201, Melbourne, New South Wales 3124.
Has Island Pharmaceuticals raised funding?
Three rounds. Latest 3 November 2024: post IPO equity, US$2,400,000.
Which companies are listed alongside Island Pharmaceuticals?
9 profiles list Island Pharmaceuticals as a peer — 79th percentile in Biotechnology Research. It lists ten peers of its own. NeuroScientific Biopharmaceuticals Ltd and Entropy Neurodynamics list it back.